---
title: "SK released its 2024 annual performance, with a net profit attributable to the parent company of 223 million yuan, a year-on-year increase of 458.19%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/236434748.md"
description: "According to the Zhitong Finance APP, SK disclosed its annual report for 2024. During the reporting period, the company achieved revenue of 2.464 billion yuan, a year-on-year increase of 0.64%; net profit attributable to the parent company was 223 million yuan, a year-on-year increase of 458.19%; net profit excluding non-recurring gains and losses was 207 million yuan, a year-on-year increase of 601.94%; basic earnings per share were 1.87 yuan. The company plans to distribute a cash dividend of 3.00 yuan (tax included) for every 10 shares to all shareholders"
datetime: "2025-04-17T13:04:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/236434748.md)
  - [en](https://longbridge.com/en/news/236434748.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/236434748.md)
generator: "portal-rs"
---

# SK released its 2024 annual performance, with a net profit attributable to the parent company of 223 million yuan, a year-on-year increase of 458.19%

According to the Zhitong Finance APP, SK (688155.SH) disclosed its 2024 annual report, reporting revenue of 2.464 billion yuan for the period, a year-on-year increase of 0.64%; net profit attributable to shareholders of 223 million yuan, a year-on-year increase of 458.19%; net profit excluding non-recurring items of 207 million yuan, a year-on-year increase of 601.94%; basic earnings per share of 1.87 yuan. The company plans to distribute a cash dividend of 3.00 yuan (including tax) for every 10 shares to all shareholders

### Related Stocks

- [688155.CN](https://longbridge.com/en/quote/688155.CN.md)

## Related News & Research

- [APT Medical: H1 2026 revenue and profit rose over 25% year-over-year, with strong growth in core segments](https://longbridge.com/en/news/296363764.md)
- [JDC: Record growth in turnover and EBITDA, with strong outlook driven by new regulation and AI](https://longbridge.com/en/news/296247395.md)
- [BRAVE: HELA's Q4 2026 launch is set amid strong engagement and improved financial stability](https://longbridge.com/en/news/296266827.md)
- [TAESA energizes Garabi 2 converter, adding about R$ 24.2 million to Saíra annual revenue entitlement](https://longbridge.com/en/news/296538089.md)
- [GN Store Nord lifts 2026 adjusted EBITA margin outlook to 9%-10%](https://longbridge.com/en/news/296382166.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**